Cart
sales@molnova.com
SCR-1481B1
CAS No. 1174161-86-4
SCR-1481B1( c-Met inhibitor 2 )
Catalog No. M20163 CAS No. 1174161-86-4
SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 200 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSCR-1481B1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
-
DescriptionSCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.(In Vitro):More details please refer to Patent WO 2009094417 A1.
-
In Vitro——
-
In Vivo——
-
Synonymsc-Met inhibitor 2
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1174161-86-4
-
Formula Weight742.07
-
Molecular FormulaC31H35ClF2N5O10P?
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL?(44.29 mM)
-
SMILESNC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Robert M. Borzilleri et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.
molnova catalog
related products
-
Cediranib
A highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.
-
Cediranib maleate
A highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.
-
Vatalanib free base
A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.
